$45.00
PT-141
Bremelanotide
Contents: PT-141
Form: Lyophilized Powder
Purity: ≥ 99% pure
Emerging Research Evidence:
Men & women rapid increase in sexual desire, erectile dysfunction & sexual performance. Short lasting peptide.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
In stock
PT-141 Overview
PT-141, known generically as bremelanotide, is an emerging therapy that works through a completely different mechanism. Originally approved as an on-demand treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women, bremelanotide is now being explored off-label for men with ED and related conditions. Dual Mechanism: PT 141 triggers nitric oxide release, which relaxes penile muscles and increases blood flow, helping men achieve an erection. Unlike other treatments that solely enhance blood flow, PT 141 also increases sexual desire, making it beneficial for individuals struggling with low libido or sexual performance. This is a short-lasting peptide. Research is ongoing and the claimed benefits are still emerging.
PT-141 Structure:
CAS Number: 189691-06-3 (free base)
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight (avg): 1,025.182 g/mol
Monoisotopic Mass: 1,024.5243 g/mol
Parent Compound: Derived from Melanotan II (MT-II); de-aminated/active metabolite of MT-II noted in literature.
Synonyms:
Research areas
Research-only note: PT-141 is not FDA-approved for therapeutic use; published effects are primarily preclinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
